CatamaranBio (@CatamaranBio) header
CatamaranBio (@CatamaranBio) profile picture

Cell Therapy Company developing allogeneic, off-the-shelf products for patients with high unmet medical need

Joined June 2020
Photo by CatamaranBio (@CatamaranBio)Photo by CatamaranBio (@CatamaranBio)Photo by CatamaranBio (@CatamaranBio)Photo by CatamaranBio (@CatamaranBio)Photo by CatamaranBio (@CatamaranBio)Photo by CatamaranBio (@CatamaranBio)Photo by CatamaranBio (@CatamaranBio)Photo by CatamaranBio (@CatamaranBio)Photo by CatamaranBio (@CatamaranBio)Photo by CatamaranBio (@CatamaranBio)
Maina Bhaman spoke with @karenjagoda about transformative #oncology therapies and recent investments in @Myricx_Pharma, a startup focused on novel NMT inhibitors in cancer, and @CatamaranBio, a company focused on CAR-NK cell therapies. hubs.ly/H0GBlh20
Last December, five biotech entrepreneurs and scientists entered Yvonne’s, the cozy supper club and bar, to discuss a new potential biotechnology company to fight cancer. Catamaran Bio was unveiled Monday with $42 million in funding. bos.gl/5sVku5G